Systematic Review Registration: CRD42024554513
Folic acid antagonists can be divided into two groups: (a) DHFR inhibitors (eg, sulfamethoxazole-trimethoprim), which block the conversion of folate to its more active metabolites (Figure 1), and (b) other folic acid antagonists, a group consisting primarily of anticonvulsant medications (phenobarbital, phenytoin, primidone, and carbamazepine) but also including Spasmophen (an antispasmodic drug that contains low doses of phenobarbital) and cholestyramine
These treatments use L-glutathione, the active and potent form of the antioxidant, to get effective results
TB-500, while sharing these actin-related effects, remains particularly useful for studying local cytoskeletal behavior in isolation
It neutralizes free radicals, reduces oxidative stress, and supports the bodys detoxification processes